Assessing and improving adherence with multidrug therapy
Authors:
- Janine ThoulassJTJanine Thoulass
- W. Cairns S. SmithWSW. Cairns S. Smith
Open Access
- 1 September 2012
- journal article
- review article
- Published by Lepra in Leprosy Review
- Vol. 83 (3) , 282-291
Abstract
Introduction: Adherence with multidrug therapy (MDT) in the treatment of leprosy is important to minimise the risk of relapse and avoid the emergence of drug resistance. Adherence is defined as the extent to which the patient’s behaviour matches recommendations from the prescriber. This paper reviews the methods for assessing adherence with MDT in leprosy, and community approaches to improving adherence based on evidence from the treatment of tuberculosis (TB) and HIV, as well as leprosy. Methods: To identify and summarise the available literature regarding the assessment of treatment regularity in leprosy, a literature search of MEDLINE was conducted using the following search terms: ‘leprosy’ AND (‘adherence’ OR ‘compliance’ OR ‘concordance’). To identify evidence for interventions that have involved community members in HIV, TB or leprosy adherence support, a literature search was conducted using the key terms and medical subject headings ‘treatment or adherence’ ‘community,’ ‘HIV, TB or Leprosy’ and ‘low and middle income countries’ combined using Boolean operators. Results: Leprosy programmes routinely use defaulting and treatment completion as proxy measures of adherence as recommended by the WHO global strategy. However, a number of other methods have been used to assess adherence including questionnaires, pill counts, as well as direct measures based on testing urine for the presence of dapsone. Direct methods were extensively used during the dapsone mono-therapy era but there is little evidence of their use in MDT. Use of multiple methods of assessing adherence improves the accuracy and reliability of the results. Community activities in TB and HIV such as variants of treatment observation, and/or wider programmes of counselling or direct support to the patient or their family or to increase community or social support were shown to improve treatment outcomes. Outcomes evaluated included treatment default and completion, clinical indicators, and adherence (pill-count, self report). Conclusions: Adherence is very important in leprosy and regular assessment of medication adherence together with constructive feedback and counselling of patients is likely to be beneficial. Leprosy programme can learn from adherence support interventions developed by both TB and HIV programmes.Keywords
This publication has 30 references indexed in Scilit:
- Improving Clinic Attendance and Adherence to Antiretroviral Therapy Through a Treatment Supporter Intervention in Uganda: A Randomized Controlled TrialAIDS and Behavior, 2011
- Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapyAIDS, 2010
- Noncompliance with the World Health Organization-Multidrug Therapy Among Leprosy Patients in Cebu, Philippines: Its Causes and Implications on the Leprosy Control ProgramDermatologic Clinics, 2008
- Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in AfricaAIDS Care, 2007
- Acceptability of community and health facility-based directly observed treatment of tuberculosis in Tanzanian urban settingHealth Policy, 2006
- Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trialThe Lancet, 2006
- Cost-effectiveness analysis of an alternative tuberculosis management strategy for permanent farm dwellers in South Africa amidst health service contractionScandinavian Journal of Public Health, 2006
- Evaluation of efficacy of community‐based vs. institutional‐based direct observed short‐course treatment for the control of tuberculosis in Kilombero district, TanzaniaTropical Medicine & International Health, 2003
- From social integration to health: Durkheim in the new millenniumSocial Science & Medicine, 2000
- Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999